← All companies

SNGX

Soligenix, Inc.

SNGX Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.38

+0.01 +2.03%

Key statistics

from XBRL data in SEC filings

Market cap

$5.60M

Revenue (TTM)

$495K

Net income (TTM)

-$11.0M

EPS (TTM)

$-1.45

P/E ratio

—

Dividend yield

—

Free cash flow

-$10.3M

Cash

$6.03M

Total assets

$6.92M

Gross margin

19.7%

52-week range

$0.28 – $6.23

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jun 26, 2026 8-K Delisting notice or listing-rule failure; Director or officer change; Other events Jun 12, 2026 8-K Other events May 28, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Other events Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Other events Feb 12, 2026 8-K Other events Jan 23, 2026 8-K Delisting notice or listing-rule failure Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Entered a material agreement; Other events Sep 29, 2025 8-K Other events Aug 18, 2025 8-K Delisting notice or listing-rule failure Aug 15, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Other events Jul 31, 2025 8-K Director or officer change; Shareholder vote results Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Amended charter or bylaws Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 21, 2025 8-K Terminated a material agreement Feb 10, 2025 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Entered a material agreement; Took on a direct financial obligation Oct 11, 2024 8-K Other events Aug 16, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Entered a material agreement Jul 25, 2024 8-K Entered a material agreement; Unregistered sale of equity Jul 9, 2024 8-K Modified rights of security holders; Director or officer change; Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure May 31, 2024 8-K Shareholder vote results; Regulation FD disclosure May 24, 2024 8-K Other events May 17, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Entered a material agreement; Other events Apr 22, 2024 8-K Other events Apr 3, 2024 10-K Fiscal year ended 2023-12-31 Mar 15, 2024 8-K Delisting notice or listing-rule failure Dec 22, 2023 8-K Shareholder vote results Dec 15, 2023 8-K Shareholder vote results; Regulation FD disclosure Nov 17, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Shareholder vote results; Regulation FD disclosure Oct 20, 2023 8-K Shareholder vote results; Regulation FD disclosure Sep 22, 2023 8-K Changed accountants; Other events Sep 15, 2023